Write your message
Summer (In Press)                   Back to the articles list | Back to browse issues page

XML Print


1- Associate Professor of Gyneco-oncology, Preventative Gynecology Research Center, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- Fellowship of Gyneco-oncology, Department of Gyneco-oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- Fellowship of Gyneco-oncology, Department of Obstetrics and Gynecology, Iran University of Medical Sciences, Tehran, Iran
4- Associate Professor of Gyneco-oncology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
5- Associate Professor of Pathology. Department of Pathology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6- Fellowship of Gyneco-oncology, Preventative Gynecology Research Center, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran , m_talayeh@yahoo.com
Abstract:   (132 Views)

Background & Objective: Endometrial carcinoma is the most common malignancy of the female genital tract, which most often affects postmenopausal women. The ovaries may be active when a patient has endometrial cancer, so removing an ovary can worsen a patient's quality of life. On the other hand, a complete surgical staging in endometrial cancer includes oophorectomy since 1988. There has been some research to assess whether an oophorectomy should be performed and in which cases, ovaries can be preserved.
Materials & Methods: Aim of this study was to evaluate the coexistence of ovarian involvement in endometrioid endometrial carcinoma. In this study, we evaluated 180 patients with endometrioid endometrial cancer patients who were surgically staged at Imam Hossein Hospital between 2004 and 2017.
Results: Mean age of subjects of the study was 56.78 ±10.59. Forty-six of patients (25.6 %) were less than 50 years old and 74.4 % (134) were older than 50. Twenty out of 180 (11.1 %) of them had ovarian involvement (one of them had simultaneous ovarian tumor) and 11 (55%) of these cases were less than 50 years old. In 55 % (11) patients, the involved ovaries were less than 5 cm with grossly normal appearance, lymph nodes metastases were detected in 3 out of 20 (15 %) of them although their ovarian size were 4, 4.5 and 6.5 cm. In 10 (50 %) of them, deep myometrial invasion was detected.
Conclusion: In endometrial cancer staging, ovarian preservation could be a challenging decision and a real controversy which needs more researches.

     
Systematic Review: Original Research | Subject: Gynecology Oncology
Received: 2021/04/5 | Accepted: 2021/04/12

References
1. Lee TS, Jung JY, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol. 2007 Jan 1;104(1):52-7. [DOI:10.1016/j.ygyno.2006.07.003] [PMID]
2. Gu H, Li J, Gu Y, et al. Survival Impact of Ovarian Preservation on Women With Early-Stage Endometrial Cancer: A Systematic Review and Meta-analysis International. J Gynecol Cancer 2017;27: 77-84. [DOI:10.1097/IGC.0000000000000857] [PMID]
3. Lau H.Y, Twu N.F, Yen M.S et al.. Impact of ovarian preservation in women with endometrial cancer. J Chinese Medic Assoc. 2014;77(7): 379-84. [DOI:10.1016/j.jcma.2014.05.002] [PMID]
4. Jia P, Zhang Y. Ovarian preservation improves overall survival in young patients with early-stage endometrial cancer. Oncotarget. 2017 Aug 29;8(35):59940. [DOI:10.18632/oncotarget.18404] [PMID] [PMCID]
5. Kinjyo Y, Kudaka W. Ooyama T. etl al.Ovarian preservation in young women with endometrial cancer of endometrioid histology. Acta Obstet Gynecol Scandinavia; 94 (2015), 430-4. [DOI:10.1111/aogs.12588] [PMID]
6. Shamshirsaz A.A, Withiam-Leitch M, Odunsi K et al.Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecol Oncol. 2007;104: 757-60 [DOI:10.1016/j.ygyno.2006.11.013] [PMID]
7. Lee TS, kim JW, Kim TJ, et al. Ovarian preservation during the surgical treatment of earlystage endometrial cancer: A nation-wide study conducted by Korean Gynecologyic-Oncology group; Gynecol Oncol. 2009; 115: 20-31. [DOI:10.1016/j.ygyno.2009.06.041] [PMID]
8. Carneiro MM, Lamaita RM, Ferreira MC et al. Fertility-preservation in endometrial cancer: is it safe? Review of the literature. JBRA Assist Reprod. 2016;20:232-9. [DOI:10.5935/1518-0557.20160045] [PMID] [PMCID]
9. Lim MC, Won YJ, Ko MJ, Kim M, Shim SH, Suh DH, et al. Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015. J Gynecol Oncol. 2019;30:e38. [DOI:10.3802/jgo.2019.30.e38] [PMID] [PMCID]
10. Jia P, Zhang Y. Ovarian preservation improves overall survival in young patients with early-stage endometrial cancer. Oncotarget. 2017;8:59940-9. [DOI:10.18632/oncotarget.18404] [PMID] [PMCID]
11. Shin W, Park SY, Kang S, Lim MC, Seo SS. The survival effect of ovary preservation in early stage endometrial cancer: a single institution retrospective analysis. J Ovarian Res. 2020 Dec;13(1):1-7. [DOI:10.1186/s13048-020-00698-5] [PMID] [PMCID]
12. van Dorp W, Haupt R, Anderson RA, et al. Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. J Clin Oncol. 2018;36:2169-80. [DOI:10.1200/JCO.2017.76.3441] [PMID] [PMCID]
13. Chemaitilly W, Li Z, Krasin MJ, et al. Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude lifetime cohort. J Clin Endocrinol Metab. 2017;102(7):2242-50 [DOI:10.1210/jc.2016-3723] [PMID] [PMCID]
14. Walsh ch., Holschneider ch., Haang Y. et al; Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005; 106: 693-9. [DOI:10.1097/01.AOG.0000172423.64995.6f] [PMID]
15. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36:1994-2001. [DOI:10.1200/JCO.2018.78.1914] [PMID]
16. Chaoyang S, Gamg C, Zongyuan Y, et al. Safety of ovarian preservation in young patients with early-stage endometrial cancer; a retrospective study and meta-analysis. Fertil Steril. 2013; 100: 702-88.
17. Sun C, Chen G, Yang Z, Jiang J, Yang X, Li N, et al. Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis. Fertil Steril. 2013;100:782-7 [DOI:10.1016/j.fertnstert.2013.05.032] [PMID]
18. Koskas M, Bendifallah S, Luton D, et al; Safety of uterine and/or ovarian preservation with grade 1 intramucous endometrial adenocarcinoma; a comparison of survival according to the extent of surgery. Fertil Steril. 2012; 98: 1229-35. [DOI:10.1016/j.fertnstert.2012.07.1142] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2021 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.